| Reference | 1: Wu Z, Chang J, Ren W, Hu Z, Li B, Liu H. Bindarit reduces the incidence of
acute aortic dissection complicated lung injury via modulating NF-κB pathway. Exp
Ther Med. 2017 Sep;14(3):2613-2618. doi: 10.3892/etm.2017.4830. Epub 2017 Jul 25.
PubMed PMID: 28962202; PubMed Central PMCID: PMC5609298.
<br>
2: Wolf S, Johnson S, Perwitasari O, Mahalingam S, Tripp RA. Targeting the
pro-inflammatory factor CCL2 (MCP-1) with Bindarit for influenza A (H7N9)
treatment. Clin Transl Immunology. 2017 Mar 31;6(3):e135. doi:
10.1038/cti.2017.8. eCollection 2017 Mar. PubMed PMID: 28435679; PubMed Central
PMCID: PMC5382437.
<br>
3: Paccosi S, Giachi M, Di Gennaro P, Guglielmotti A, Parenti A. The chemokine
(C-C motif) ligand protein synthesis inhibitor bindarit prevents cytoskeletal
rearrangement and contraction of human mesangial cells. Cytokine. 2016
Sep;85:92-100. doi: 10.1016/j.cyto.2016.06.012. Epub 2016 Jun 13. PubMed PMID:
27309675.
<br>
4: Colombo A, Basavarajaiah S, Limbruno U, Picchi A, Lettieri C, Valgimigli M,
Sciahbasi A, Prati F, Calabresi M, Pierucci D, Guglielmotti A. A double-blind
randomised study to evaluate the efficacy and safety of bindarit in preventing
coronary stent restenosis. EuroIntervention. 2016 Dec 10;12(11):e1385-e1394. doi:
10.4244/EIJY15M12_03. PubMed PMID: 26690313.
<br>
5: Chen W, Foo SS, Taylor A, Lulla A, Merits A, Hueston L, Forwood MR, Walsh NC,
Sims NA, Herrero LJ, Mahalingam S. Correction for Chen et al., Bindarit, an
Inhibitor of Monocyte Chemotactic Protein Synthesis, Protects against Bone Loss
Induced by Chikungunya Virus Infection. J Virol. 2015 Dec;89(23):12232. doi:
10.1128/JVI.02114-15. PubMed PMID: 26543092; PubMed Central PMCID: PMC4645307.
<br>
6: Zoja C, Corna D, Locatelli M, Rottoli D, Pezzotta A, Morigi M, Zanchi C,
Buelli S, Guglielmotti A, Perico N, Remuzzi A, Remuzzi G. Effects of MCP-1
inhibition by bindarit therapy in a rat model of polycystic kidney disease.
Nephron. 2015;129(1):52-61. doi: 10.1159/000369149. Epub 2014 Dec 17. PubMed
PMID: 25531096.
<br>
7: Chen W, Foo SS, Taylor A, Lulla A, Merits A, Hueston L, Forwood MR, Walsh NC,
Sims NA, Herrero LJ, Mahalingam S. Bindarit, an inhibitor of monocyte chemotactic
protein synthesis, protects against bone loss induced by chikungunya virus
infection. J Virol. 2015 Jan;89(1):581-93. doi: 10.1128/JVI.02034-14. Epub 2014
Oct 22. Erratum in: J Virol. 2015 Dec 1;89(23):12232. PubMed PMID: 25339772;
PubMed Central PMCID: PMC4301140.
<br>
8: Steiner JL, Davis JM, McClellan JL, Guglielmotti A, Murphy EA. Effects of the
MCP-1 synthesis inhibitor bindarit on tumorigenesis and inflammatory markers in
the C3(1)/SV40Tag mouse model of breast cancer. Cytokine. 2014 Mar;66(1):60-8.
doi: 10.1016/j.cyto.2013.12.011. Epub 2014 Jan 20. PubMed PMID: 24548426; PubMed
Central PMCID: PMC4419732.
<br>
9: Severini C, Passeri PP, Ciotti M, Florenzano F, Possenti R, Zona C, Di Matteo
A, Guglielmotti A, Calissano P, Pachter J, Mercanti D. Bindarit, inhibitor of
CCL2 synthesis, protects neurons against amyloid-β-induced toxicity. J Alzheimers
Dis. 2014;38(2):281-93. doi: 10.3233/JAD-131070. PubMed PMID: 23948942.
<br>
10: Maddaluno M, Grassia G, Di Lauro MV, Parisi A, Maione F, Cicala C, De
Filippis D, Iuvone T, Guglielmotti A, Maffia P, Mascolo N, Ialenti A. Bindarit
inhibits human coronary artery smooth muscle cell proliferation, migration and
phenotypic switching. PLoS One. 2012;7(10):e47464. doi:
10.1371/journal.pone.0047464. Epub 2012 Oct 15. PubMed PMID: 23077623; PubMed
Central PMCID: PMC3471825.
|
